chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The very next day, I started having a terrible headache, and high blood pressure. It was almost as if I was having a TA. I could barely speak. I couldn?t form my words right. I was fatigued terrible and developed arrythmia.  I rested and called my PCP. I did intake of fluids. I have been extremely anemic as well. I have been getting Iron Infusions IVs.  All of this a continuance of what I reported on the first shot.
Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 076C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Nov-2021 at 6:11 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 19-Nov-2021 at 6:11 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient's race was reported.  It was reported that patients were given doses from vials that were stored in an ultracold freezer which was colder than should had been. Vaccine was stored in an ultra-cold freezer at minus 82 degrees Fahrenheit. Storage condition at the time of the excursion was frozen storage and excursion duration was 1 month.  Date when vials moved from freezer to refrigerator was 19-Nov-2021 and Moderna COVID-19 vials went from the super cold freezer to the refrigerator. No vaccine state changes were noticed, and vaccine was never refrozen. None of the vials were punctured. No Previous temperature excursions was reported.  No concomitant medication was reported. No treatment information was provided.   The patient was administered vaccine that was stored at temperature between minus 80-degree F to minus 84-degree F. It was unknown if patient had allergy to medications, food, and other products. It was unknown if the patient was ever diagnosed with or tested positive for COVID-19. Patient's acute illness at the time of vaccination and up to one month before was unknown. Chronic or long-standing health conditions were unknown. Prescription, over-the-counter medications, dietary supplements, or herbal remedies being taken at the time of vaccination and or at the time of the adverse event was unknown.   This case was linked to MOD-2021-402935 (Patient Link).
Information has been received from a pharmacist concerning an adult male who on 24-JUN-2010 was supposed to get PNEUMOVAX 23 and by mistake received PREVNAR 13. The patient did not received PNEMOVAX 23, only PREVNAR 13 by mistake. The patient was not experiencing any known symptoms. No further information is available at this time of reporting. Follow-up information has been received from the pharmacist who reported that it was a case of the wrong product being grabbed by mistake. He stated that the two products did not look alike at all. Additional information is not expected.
left side of neck was very sore; felt a swollen lump /lymph about halfway between my ear and bottom of my neck; This is a spontaneous report from a contactable consumer (Patient). A 48-year-old female patient (also the age at vaccination) received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: unknown: Unable to locate or read the details), via an unspecified route of administration at the left arm on 23Jan2021 12:45 PM at SINGLE DOSE for Covid-19 immunization.  Medical history included Chiari Malformation (reported as other medical history). The patient has no COVID prior to vaccination, also not COVID tested post vaccination. The patient had no known allergies. The patient is not pregnant. There was no other vaccine in four weeks. It was reported that the patient had other medications in two weeks (unspecified). The patient had the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on 02Jan2021 at 12:45 PM at the left arm for COVID-19 immunization (Lot number not reported: Unable to locate or read the details, facility type vaccine: Other). It was reported by the patient that: "I woke up this morning (on 31Jan2021 at 08:00 AM) and my left side of neck was very sore. I went to rub it and immediately felt a swollen lump /lymph about halfway between my ear and bottom of my neck. It is about the size of a dime. My second dose was 8 days ago (23Jan2021). I am assuming this is normal response to Pfizer vaccine, but all I read said reactions should be over 2 to 4 days after vaccine. Is this considered normal or should I contact my PCP? " No treatment was received. The outcome of the events was not recovered.   Information about Lot and batch number has been requested.
On 3/14/2013, I received a ZOSTAVAX injection in the back of my upper left arm. The injection was administered by a Pharmacist. Within a week of receiving the injection I began to experience pain around my left shoulder and scapula and radiating down the left arm. Initially, I thought I may have injured my neck, as the pain was similar to that of a pinched nerve I had several years previously. When I went to see a physician in early April he ordered x-rays and an MRI of the neck. After reviewing these he concluded that the symptoms did not match anything noted on the tests. By this time the pain was subsiding and I was left with a weakness in the lower left arm and hand, primarily on extension. He suggested that it appeared to be Parsonage Turner Syndrome. He then ordered an EMG to test nerve conduction. The EMG showed that it was primarily the ulnar nerve that was affected. It was not until later when I got home and looked up information on Parsonage Turner Syndrome that I realized the probable connection between the vaccination and the symptoms. I have since seen a neurologist who agreed that it was probably Parsonage Turner Syndrome and that there could be a connection between the vaccination and my symptoms. I continue to have weakness in my left hand and an inability to extend the fingers.
Pain in joints of fingers, hands, wrists, ankles. Swelling in fingers. Swollen lymph nodes in neck. Swelling in lymph nodes and ankle pain lasted approx 2 days. Pain/swelling in hands persisted several weeks. Pt c/o carpal tunnel sx on 12/15/04. She was advised to wear wrist splints. Presently joint pain & swelling has resolved. As of 1/6/05 pt continued to report carpal tunnel sx.
Mild Variola reaction with sparse, disseminated pustules.  Some malaise, fatigue, chills, fever unknown.  Vaccine administered 30 Jan, symptoms began 8 days after vaccination.  Also had possible secondary bacterial infection (cellulitis).  Patient treated with VIG, antibiotics, made full, rapid recovery.
slight headache; muscle cramps; lymph node pain under arm; This is a spontaneous report from a contactable consumer, the patient. A 77-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6200) via an unspecified route of administration in the right arm on 24Feb2021 at 13:30(at the age of 77-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes, heart attack and bypass surgery. The patient had a history of allergy to ciprofloxacin (CIPRO). Concomitant medications included atorvastatin (MANUFACTURER UNKNOWN), glimepiride (MANUFACTURER UNKNOWN), montelukast sodium (VICTOR) and metoprolol succinate (METOPROLOL) all for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9264) via an unspecified route of administration in the right arm on 05Feb2021 at 14:00(at the age of 77-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination.  On 24Feb2021, the patient experienced slight headache for a month which was still continuing, muscle cramps for 2 days and had lymph node pain under arm when lying on side with arm under body which started two weeks after shot and continued for several weeks. The patient did not receive any treatment for the reported events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event muscle cramps was resolved on 20210226. The clinical outcome of the events slight headache and lymph node pain under arm were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Patient had redness, swelling, soreness and knot at the site of the injection. It last about 2 weeks, No fever
We received an email today, 6/3/2021, from patients supervisor stating that approximately 30-45 minutes after we left the vaccine clinic, that the patient had a seizure or seizures.  She does have a history of epilepsy.  She was unconscious and had to be taken by ambulance to the hospital.  She has recovered now and is resting at home.   She was advised not to take her 2nd dose.
Allergic reaction; This case was reported by a other health professional via interactive digital media and described the occurrence of allergic reaction in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced allergic reaction. On an unknown date, the outcome of the allergic reaction was unknown.   It was unknown if the reporter considered the allergic reaction to be related to Shingrix.     Additional Information: GSK Receipt Date: 22-Sep-2022 Reporter's comment: This case was reported by the patient via interactive digital media. The patient had an allergic reaction to Shingrix. The patient had asked advised for the second dose. Additional supportive information: The follow-up would not possible, as no contact details were available.
Patient received 1st dose of shingrix. Within a few minutes, the patient was sitting down and appeared to be in shock (eyes rolling back, initially unresponsive, symptoms relating to stroke- speech delay/trouble forming words/slow, uncoordinated movement). I had the customer at pick up call 911 as I announced code white (I was alone in the pharmacy). I then quickly wheeled the IMZ cart to her. She was breathing, but I was concerned she would enter cardiac arrest and felt for her pulse, which felt normal. After a minute or two, she was able to respond. She denied any itching, closing of throat, or trouble breathing. No visible hives or rash. Patient began to fall backwards, but her husband and I kept her upright. She vomited. I gave her an ice pack, water, felt for her pulse (felt normal), and attempted to check her blood pressure while waiting for EMT. Patient started to feel better after vomiting and drinking a bottle of water. EMT checked vitals when they arrived and determined she was okay to go home
pt recv vax 15SEP98 devel small pinpoint raised area 17SEP98 morning rash was all over body, disappeared by 19SEP98;no itching, no med to tx;no fever;
On Jan 22, Developed sudden onset of left hand swelling , progressed to left hand throbbing pain with decreased ability to preform  simple task.  treated rleased / march  23- developed same symptoms  / march 28th  recurrent symtoms.  On 1/22/21 treated at ER w/ oral predisone , with improvement. / 0n jan 25th eval at  Health Center .  for Eval/ On march 23 seen at ER for recurrent symtoms . Had Xray, treated with oral prednisone // On 3/28  recurrent symptoms.
This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (back was wide open hurting/ bad back ache), MUSCULAR WEAKNESS (legs were weak), DIZZINESS (lightheaded that she had to hold on to the counter, oozy), INFLUENZA LIKE ILLNESS (flu-like symptoms) and FATIGUE (fatigue) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported.On 19-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form.On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Nov-2021, the patient experienced BACK PAIN (back was wide open hurting/ bad back ache), MUSCULAR WEAKNESS (legs were weak), DIZZINESS (lightheaded that she had to hold on to the counter, oozy), INFLUENZA LIKE ILLNESS (flu-like symptoms), FATIGUE (fatigue) and CHILLS (chills). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency. At the time of the report, BACK PAIN (back was wide open hurting/ bad back ache), MUSCULAR WEAKNESS (legs were weak), DIZZINESS (lightheaded that she had to hold on to the counter, oozy), INFLUENZA LIKE ILLNESS (flu-like symptoms), FATIGUE (fatigue) and CHILLS (chills) was resolving. No concomitant medication was reported by the reporter.Patient felt better after using heating pad.
Expired Havrix was inadvertently administered to a patient; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 51-year-old male patient who received HAV (Havrix adult) (batch number H4H53, expiry date 30-JAN-2023) for prophylaxis.   On 01-JUN-2023, the patient received Havrix adult (right arm). On 01-JUN-2023, an unknown time after receiving Havrix adult, the patient experienced expired vaccine used (Verbatim: Expired Havrix was inadvertently administered to a patient). The outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 02-JUN-2023 The reporter reported that an expired Havrix dose was inadvertently administered to a patient which led to expired vaccine used. The reporter enquired if the patient should be revaccinated and mentioned patient was okay, well, healthy and has been notified. The reporter did not consent to follow-up.
Patient was given both PEDIARIX and IPV at same visit (7/20/17).
The patient reported pain in the arm right after injection. She states the pain has continued. The pain is so much that she can't lift her arm. She is seeking treatment and diagnosis from a shoulder specialist for a vaccine injury.
weakness, headache, upset stomach, sore arm, body ache chills joints ache diarrhea vomiting, dizzy
if could be affecting hypothalamus; Has a brace on his knee; 4-5 days chills; felt like he was going to freeze to death/Got cold in the shower; Pain in his left leg; He has difficult with balance. Worse it has ever been. Has to be very careful to keep from falling; Walked with a cane for 4-5 weeks; This is a spontaneous report received from a contactable reporter(s) (Physician) from medical information team.A 85 year-old male patient received bnt162b2 (COMIRNATY), administration date 23Feb2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (First Dose), for COVID-19 immunization.The following information was reported: HYPOTHALAMO-PITUITARY DISORDER (medically significant), outcome "unknown", described as "if could be affecting hypothalamus";JOINT STABILISATION (medically significant), outcome "unknown", described as "Has a brace on his knee"; CHILLS (non-serious), outcome "unknown", described as "4-5 days chills"; FEELING COLD (non-serious), outcome "unknown", described as "felt like he was going to freeze to death/Got cold in the shower"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "Pain in his left leg"; BALANCE DISORDER (non-serious), outcome "unknown", described as "He has difficult with balance. Worse it has ever been. Has to be very careful to keep from falling"; WALKING AID USER (non-serious), outcome "unknown", described as "Walked with a cane for 4-5 weeks". Therapeutic measures were taken as a result of joint stabilisation. clinical information: Second dose 23Feb2021. 4-5 days chills, felt like he was going to freeze to death. Pain in his left leg. These symptoms have not gotten better, still gets the chills. He was asking if this has been reported, He has difficult with balance. Worse it has ever been. Has to be very careful to keep from falling. Got cold in the shower. Asking if could be affecting hypothalamus. Walked with a cane for 4-5 weeks. Endure rehab. Has a brace on his knee and received a cortisone shot. Before dose he was walking 3-5 miles. Has seen providers at a medical facility. Some recommended he go to (name withheld). He states he can live with it, but wanted to report his findings. He requests escalation for further research on the duration of symptoms. The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events Hypothalamo-pituitary disorder and Joint stabilization cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
July 2022 experienced weakness of lip muscles when chewing and difficulty with speech. Shortly after noticed a mild eyelid droop of the right upper eyelid. December 28, 2022 I was diagnosed with Myasthenia Gravis and prescribed pyridostigmine 60mg.
Given HPV & MENACTRA @ 08:30 AM Fever Pm - abd pain & facial hives - given BENADRYL - went ER @ 6 PM. Given IV steroids & BENADRYL - Home with ORAPRED & BENADRYL - face red & sore throat next AM 24 hr later.
On 1/20/20 I was 5 weeks 6 days pregnant and had the second dose of the Covid-19 vaccine.  My expected due date 9/17/21. In the evening my arm started to get extremely sore at the injection site followed by body aches and a severe headache that last 48 hours. By Friday evening around b 7 pm I ended up throwing up and started to feel relief. Waking Saturday morning I had cramping and vaginal bleeding. After a trip to the er at 2 pm I had a ULTRASOUND which did not show a fetal heart tone. As of today Thursday 1/28/21 I am still bleeding. The headache has come and gone since the severity let up on friday
Patient has developed Bell's Palsy as of 9/14/2021. He had also been experiencing random swelling around his wrist bone and then both knees swelled up causing severe pain when he walked. Bedrest helped the swelling. This started approximately 9/3/2021. Within the same week he started having severe back and neck pain causing him to not be able to sleep for more than an hour. The following week on the 14th we ended up taking him to the ER for stroke symptoms and that's when he was diagnosed with Bell's. Palsy.
Red area of inflammation occurred immediately after injection given at injection site. Red are had pin point areas and facial areas also flushed. MD notified and he gave instructions to no give further vaccines and continue to observe. Pulse and resp WNL. Lungs clear. Redness resolved. Mom said possible allergies/asthma - no swelling - no coughing - no wheezing. Referred to FMP for evaluation - FMP notified as well.
Vaccines given early. No adverse reaction noted from patient. CNP healthcare professional F/U with Mother evening of 11/11/2021.
Parent wrote the wrong birthday year down on the Vaccination Consent Form, making her 12 years old, instead of her actual age of 11 years old.  Not discovered by provider until 5 days later.  No treatment required.
08-14-08 had high temp- did not take temp- loss of appetite, languid, sleeplessness, 08-14-08 to 08-17-08-08-22-08 phlegmy cough started & still has- diarrhea 09-03-08 ti 09-04-08- fever 09-07-08 still no temp taken- did not go to MD- still has not gone to MD- I encouraged client's mother to go to MD
About 2 wks after getting IM flu injection noticed a dark purplish indentation at injection site about 1 1/2" in diameter and 1/4" deep. Saw primary care doctor who said it was a fat necrosis (on Nov. 4th). Site still looks the same - has seen no improvement - denies pain.
ITCH CONFLUENT, ERYTHEMATOUS RASH TO TRUNK, ARMS  AND LEGS INTERMITTANTLY X 2 DAYS.
Pt recvd Hep B vax following vax pt exp fatigue, weakness & elevated liver enzymes; lab eval revealed no detectable anti-HBsAg level;
I got my 2nd dose on Wednesday and felt fine all night.  On Thursday, I started to have a low grade fever with body aches and tiredness.  On Thursday night about 6pm, I developed severe swelling under my left arm and down the left side of my ribs.
not being able to walk; joint pain; fever, fever getting worse; rash; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of GAIT INABILITY (not being able to walk), ARTHRALGIA (joint pain) and PYREXIA (fever, fever getting worse) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Apr-2021, the patient experienced GAIT INABILITY (not being able to walk) (seriousness criterion hospitalization), ARTHRALGIA (joint pain) (seriousness criterion hospitalization) and PYREXIA (fever, fever getting worse) (seriousness criterion hospitalization). 21-Apr-2021, the patient experienced RASH (rash). The patient was hospitalized on 26-Apr-2021 due to ARTHRALGIA, GAIT INABILITY and PYREXIA. At the time of the report, GAIT INABILITY (not being able to walk), ARTHRALGIA (joint pain), PYREXIA (fever, fever getting worse) and RASH (rash) had not resolved.            Action taken with mRNA-1273 in response to the events was not Applicable. Concomitant and treatment information not provided. Company comment:Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   This case was linked to MOD-2021-097707 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.